Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod

Clinical trial NCT06860633 · RECRUITING

Trial details

NCT number: NCT06860633
Sponsor: University of Colorado, Denver
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Myasthenia Gravis Crisis Myasthenia Gravis Exacerbations AChR Myasthenia Gravis

Start date: 2025-03-06
Primary completion: 2026-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.